Hypertension Management in Pregnancy: Treatment Thresholds and Aspirin Use
For chronic hypertension in pregnancy, initiate antihypertensive treatment at BP ≥140/90 mm Hg; for gestational hypertension and preeclampsia, treat acutely at ≥160/110 mm Hg per ACOG guidelines, and prescribe low-dose aspirin (81 mg daily) starting at 12 weeks gestation for all women at high risk for preeclampsia. 1, 2
Blood Pressure Treatment Thresholds
The treatment threshold depends critically on the type of hypertensive disorder:
Chronic Hypertension in Pregnancy
- Initiate treatment at BP ≥140/90 mm Hg 1
- This recommendation is based on the landmark CHAP trial, which demonstrated that treating mild chronic hypertension to maintain BP <140/90 mm Hg improves perinatal outcomes without increasing maternal or fetal complications
- ACOG and the Society of Maternal Fetal Medicine both endorse this threshold for chronic hypertension 1
Gestational Hypertension and Preeclampsia
- ACOG recommends acute treatment at BP ≥160/110 mm Hg (severe hypertension) 1
- This higher threshold reflects the lack of evidence that treating nonsevere hypertension in gestational hypertension or preeclampsia prevents adverse outcomes or delays delivery 1
- Important caveat: International guidelines differ—the National Institute for Health and Care Excellence and the International Society for the Study of Hypertension in Pregnancy recommend treatment at ≥140/90 mm Hg for all hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia 1
Severe Features Requiring Immediate Action
- BP ≥160/110 mm Hg constitutes a hypertensive emergency requiring immediate treatment
- Preeclampsia with severe features warrants delivery (definitive treatment), particularly at ≥34 weeks gestation 1
- Administer intravenous magnesium sulfate for seizure prophylaxis in severe preeclampsia 1
Low-Dose Aspirin for Preeclampsia Prevention
Yes, low-dose aspirin should be used for high-risk patients.
Who Should Receive Aspirin
Women at high risk for preeclampsia include those with: 2
- History of preeclampsia, especially early-onset (<34 weeks) or in multiple pregnancies
- Chronic hypertension
- Chronic kidney disease
- Diabetes (type 1 or 2)
- Autoimmune disease (e.g., lupus, antiphospholipid syndrome)
- Multifetal pregnancies
Women with multiple moderate risk factors (≥2 of the following): 2
- First pregnancy
- Age ≥40 years
- Pregnancy interval >10 years
- BMI ≥35 kg/m²
- Family history of preeclampsia
Dosing and Timing
- Dose: 81 mg daily (low-dose aspirin) 2
- Start: 12 weeks gestation (ideally between 12-16 weeks) 2, 4
- Stop: 36-37 weeks gestation or at delivery 2, 4
Evidence Strength
The USPSTF (2014) issued a Grade B recommendation for low-dose aspirin in high-risk women, indicating high certainty that the net benefit is moderate 2. This represents a significant shift from their 1996 recommendation when evidence was insufficient. Multiple international guidelines (ACOG, WHO, NICE, American Heart Association) now uniformly recommend aspirin for high-risk patients 2.
Common Pitfalls to Avoid
Do not apply the 130/80 mm Hg threshold from nonpregnant adults to pregnancy—this has not been validated and may lead to overtreatment 1
Do not treat nonsevere gestational hypertension or preeclampsia expecting to prevent progression—evidence shows this does not delay delivery or reduce complications; the definitive treatment is delivery 1
Do not delay aspirin initiation—starting after 16 weeks significantly reduces efficacy for preeclampsia prevention 2, 4
Do not use ACE inhibitors or ARBs—these are strictly contraindicated due to fetotoxicity 5
Remember that aspirin does not treat hypertension—it prevents preeclampsia through antiplatelet effects on placental vasculature, not by lowering blood pressure 6, 7
First-Line Antihypertensive Agents
When treatment is indicated, labetalol and nifedipine are first-line agents due to established safety and efficacy profiles in pregnancy 5. Methyldopa is also acceptable but less commonly used as first-line therapy.